Context Therapeutics
CNTX
CNTX
42 hedge funds and large institutions have $111M invested in Context Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $114M → $111M (-$3.17M)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.69M | |
| 2 | +$2.67M | |
| 3 | +$1.18M | |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
+$490K |
| 5 |
Millennium Management
New York
|
+$282K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$1.48M | |
| 3 | -$949K | |
| 4 |
ACM
Altium Capital Management
New York
|
-$722K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$584K |